Zydus gets nod to conduct Phase II clinical study in patients with CAPS in Australia

CAPS is a rare life-long auto-inflammatory condition, and is classified under orphan diseases. CAPS patients also experience multiple neurological complications like sensorineural hearing loss, migraine, headache, aseptic meningitis and myalgia.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3dIWlD1
via IFTTT